Redhill Biopharma Ltd - ADR
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Redhill Biopharma Ltd - ADR
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
/ 
Others were interested in
Frequently asked questions
To buy Redhill Biopharma Ltd - ADR stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Redhill Biopharma Ltd - ADR by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Redhill Biopharma Ltd - ADR is RDHL:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Redhill Biopharma Ltd - ADR has its primary listing on NASDAQ (Small cap). You can trade Redhill Biopharma Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Redhill Biopharma Ltd - ADR is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Redhill Biopharma Ltd - ADR as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Redhill Biopharma Ltd - ADR.